Erythema Migrans clinical trials

Explore recruiting erythema migrans clinical trials.

Recruiting erythema migrans studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Erythema Migrans trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Effect of Saccharomyces boulardii CNCM I-745 on gut microbiota in patients undergoing antibiotic therapy (in the context of erythema migrans (early skin form of Lyme borreliosis)

Slovenia, Czechia, Lithuania, Slovakia

Therapeutic use (Phase IV) EU CTIS Study details

Erythema Migrans trials by city

Erythema Migrans in Toronto Erythema Migrans in Vancouver Erythema Migrans in Montreal Erythema Migrans in Calgary Erythema Migrans in Edmonton Erythema Migrans in Ottawa Erythema Migrans in Winnipeg Erythema Migrans in Quebec City Erythema Migrans in Hamilton Erythema Migrans in Kitchener Erythema Migrans in London Erythema Migrans in Halifax Erythema Migrans in New York Erythema Migrans in Los Angeles Erythema Migrans in Chicago Erythema Migrans in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease